IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33(+) myeloma cells
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-04-15
著者
-
IQBAL Mohd
Laboratory of Cellular Signal Analysis, Department of Bio-Signal Analysis, Graduate School of Medici
-
OTSUYAMA Ken-ichiro
Laboratory of Cellular Signal Analysis, Department of Bio-Signal Analysis, Graduate School of Medici
-
SHAMSASENJAN Karim
Laboratory of Cellular Signal Analysis, Department of Bio-Signal Analysis, Graduate School of Medici
-
ASAOKU Hideki
Hiroshima Red Cross Hospital
-
Asaoku Hideki
山口大学 医学系研究科生体シグナル解析医学
-
Asaoku Hideki
Clinical Laboratory Hiroshima Red Cross Hospital Atomic-bomb Survivors Hospital
-
Asaoku Hideki
Hiroshima Red-cross Hospital
-
Shamsasenjan Karim
Laboratory Of Cellular Signal Analysis Department Of Bio-signal Analysis Graduate School Of Medicine
-
Iqbal Mohd
Laboratory Of Cellular Signal Analysis Department Of Bio-signal Analysis Graduate School Of Medicine
-
M. Kawano
Laboratory Of Cellular Signal Analysis Graduate School Of Medicine Yamaguchi University
-
ABROUN Saeid
Laboratory of Cellular Signal Analysis, Graduate School of Medicine, Yamaguchi University
-
MAHMOUD Maged
Department of Clinical Pathology, Assiut University Hospital
-
Abroun Saeid
Laboratory Of Cellular Signal Analysis Graduate School Of Medicine Yamaguchi University
-
Mahmoud Maged
Department Of Clinical Pathology Assiut University Hospital
-
Otsuyama Ken-ichiro
Laboratory Of Cellular Signal Analysis Department Of Bio-signal Analysis Graduate School Of Medicine
関連論文
- Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
- CD56 expression in human myeloma cells derived from the neurogenic gene expression : possible role of the SRY-HMG box gene, SOX4
- Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Multiple Myeloma : Results from the Japan Myeloma Study Group
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- Mikulicz's disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
- Acquired Storage-Pool Disorders Occurring Late After Allogeneic Bone Marrow Transplantation: Partial Activation of Platelets in Asymptomatic Patients
- Utility and Safety of Hickman Catheters for Venous Access after Bone Marrow Transplantation
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Endoscopic Findings of Acute Intestinal Graft-versus-host Disease after Bone Marrow Transplantation
- Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
- Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation
- Frequent Exacerbation of Pulmonary Nocardiosis during Maintenance Antibiotic Therapies in a Hematopoietic Stem Cell Transplant Recipient
- Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation
- Pneumatosis coli after Thalidomide Treatment
- Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
- Cytogenetic Abnormalities without Evidence of Relapse after Treatment with Imatinib and Stem Cell Transplantation in a Patient with Ph-Positive ALL
- Bone marrow transplantation in subjects with mental disorders
- IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33(+) myeloma cells
- An Increase in MPC-1^- and MPC-1^-CD45^+ Immature Myeloma Cells in the Progressive States of Bone Marrow Plasmacytosis : The Revised Phenotypic Classification of Monoclonal Marrow Plasmacytosis (MOMP-2005)
- Variation of Oceanic Condition in Hyuga-Nada, Japan
- Psychological factors and survival after bone marrow transplantation in patients with leukemia
- Hepatitis B Virus Reactivation in a Patient With Chronic GVHD After Allogeneic Peripheral Blood Stem Cell Transplantation
- Recombinant human erythropoetin (rhEPO) administration to marrow donors
- Imatinib Mesylate (Gleevec) in the Treatment of 2 Patients with Philadelphia-Positive ALL Relapsing after Allogeneic Stem Cell Transplantation
- Successful Unrelated Bone Marrow Transplantation After Arsenic Trioxide Treatment in a Patient With Relapsed Acute Promyelocytic Leukemia
- Erythrocytosis caused by erythropoietin-producing thymic carcinoma
- Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease
- Effect of Additional Chromosomal Abnormalities in Acute Promyelocytic Leukemia Treated With All-trans-Retinoic Acid: A Report of 17 Patients
- Second Allogeneic Peripheral Blood Stem Cell Transplantation With Fludarabine-Based Low-Intensity Conditioning Regimen for Relapsed Myelodysplastic Syndrome After Allogeneic Bone Marrow Transplantation
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes